(Q45358076)

13 December 2017

title

The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection (English)

1 reference

13 December 2017

0 references

0 references

hepatocellular carcinoma

1 reference

6

1 reference

13 December 2017

3

Noel S Weiss

1 reference

13 December 2017

George N Ioannou

1

1 reference

13 December 2017

Christopher L Bryson

series ordinal

2

1 reference

13 December 2017

Richard Miller

series ordinal

4

1 reference

13 December 2017

John D Scott

series ordinal

5

1 reference

13 December 2017

language of work or name

English

0 references

publication date

1 January 2013

1 reference

13 December 2017

1 reference

13 December 2017

volume

57

1 reference

13 December 2017

issue

1

1 reference

13 December 2017

page(s)

249-257

1 reference

13 December 2017

1 reference

7 January 2021

1 reference

7 January 2021

Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection

1 reference

7 January 2021

Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression

1 reference

7 January 2021

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

1 reference

7 January 2021

The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases

1 reference

7 January 2021

The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C.

1 reference

7 January 2021

Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis

1 reference

7 January 2021

Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States

1 reference

7 January 2021

Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes

1 reference

7 January 2021

Predictors of early treatment discontinuation among patients with genotype 1 hepatitis C and implications for viral eradication

1 reference

7 January 2021

Predictors of response of US veterans to treatment for the hepatitis C virus

1 reference

7 January 2021

The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States

1 reference

7 January 2021

Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients

1 reference

7 January 2021

Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study

1 reference

7 January 2021

Association between exposure to nevirapine and reduced liver fibrosis progression in patients with HIV and hepatitis C virus coinfection.

1 reference

7 January 2021

Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America

1 reference

7 January 2021

Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic

1 reference

7 January 2021

Hepatitis C virus is infrequently evaluated and treated in an urban HIV clinic population

1 reference

7 January 2021

Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort

1 reference

7 January 2021

Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma

1 reference

7 January 2021

Severe Liver Disease Associated With Prolonged Exposure to Antiretroviral Drugs

1 reference

7 January 2021

Improvements in subcutaneous fat, lipid profile, and parameters of mitochondrial toxicity in patients with peripheral lipoatrophy when stavudine is switched to tenofovir (LIPOTEST study).

1 reference

7 January 2021

The metabolic effects of lopinavir/ritonavir in HIV-negative men

1 reference

7 January 2021

Pharmacokinetic and tolerability profile of twice-daily saquinavir hard gelatin capsules and saquinavir soft gelatin capsules boosted with ritonavir in healthy volunteers

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.25800

1 reference

13 December 2017

1 reference